Literature DB >> 16298829

Multiple constitutional chromosome translocations of familial nature in Philadelphia chromosome-positive chronic myeloid leukemia: a report on a unique case.

Béla Kajtár1, Linda Deák, Veronika Kalász, László Pajor, Lenke Molnár, Gábor Méhes.   

Abstract

A case of Philadelphia chromosome-positive (Ph(+)) chronic myeloid leukemia (CML) featuring 2 additional balanced translocations, t(2;5) and t(6;12), as well as a robertsonian translocation, t(13;14), was diagnosed by routine bone marrow karyotyping. The breakpoints did not involve previously described CML-related chromosomal regions in any of the 3 translocations. Despite the patient's partial response following imatinib therapy, all Ph(-) bone marrow metaphases persistently had the 3 additional chromosomal changes. Moreover, stimulated peripheral B-lymphocytes from the patient also showed the same chromosomal changes, suggesting that we had found a complex constitutional chromosome aberration unrelated to the leukemia. Peripheral blood karyotype analyses of 6 of the 7 closest relatives from 3 generations demonstrated at least 1 of these aberrations, although in different combinations. Standard bone marrow or peripheral blood karyotyping of hematologic disorders may uncover otherwise symptomless, unrelated constitutional changes together with disease-specific chromosome aberrations.A triple constitutional chromosome aberration combined with a hematologic disorder has not been described until now. In addition, multiple constitutional aberrations persisting through at least 3 generations seem to be extremely rare. At present, no direct evidence exists to support a causative relationship between the familial translocations and leukemogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16298829     DOI: 10.1532/IJH97.E0504

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  Constitutional Robertsonian T(15;22) in Ph-positive CML.

Authors:  R Becher; F Wendt; D Kühn
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

2.  Ph1-positive CML in a 13;14 translocation carrier.

Authors:  S Kohno; A A Sandberg
Journal:  Med Pediatr Oncol       Date:  1978

3.  Evaluation of constitutional chromosome aberrations in hematologic disorders.

Authors:  Roxana Cerretini; Susana Acevedo; Christian Chena; Carolina Belli; Irene Larripa; Irma Slavutsky
Journal:  Cancer Genet Cytogenet       Date:  2002-04-15

Review 4.  Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis.

Authors:  A Di Bacco; K Keeshan; S L McKenna; T G Cotter
Journal:  Oncologist       Date:  2000

5.  Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

Authors:  M E O'Dwyer; K M Gatter; M Loriaux; B J Druker; S B Olson; R E Magenis; H Lawce; M J Mauro; R T Maziarz; R M Braziel
Journal:  Leukemia       Date:  2003-03       Impact factor: 11.528

6.  Ph-positive CML in a family with a constitutional Robertsonian translocation 14;15.

Authors:  R Becher; H K Mahmoud; U W Schaefer; C G Schmidt
Journal:  Cancer Genet Cytogenet       Date:  1985-11

7.  Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.

Authors:  Sherif S Farag; Amy S Ruppert; Krzysztof Mrózek; Andrew J Carroll; Mark J Pettenati; Michelle M Le Beau; Bercedis L Peterson; Bayard L Powell; Howard Ozer; Richard T Silver; Richard A Larson; Clara D Bloomfield
Journal:  Int J Oncol       Date:  2004-07       Impact factor: 5.650

8.  Characteristics of accelerated disease in chronic myelogenous leukemia.

Authors:  H M Kantarjian; D Dixon; M J Keating; M Talpaz; R S Walters; K B McCredie; E J Freireich
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

9.  Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.

Authors:  A Majlis; T L Smith; M Talpaz; S O'Brien; M B Rios; H M Kantarjian
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

Review 10.  Chronic myelogenous leukemia: molecular diagnostic considerations.

Authors:  J S McClure; C E Litz
Journal:  Hum Pathol       Date:  1994-06       Impact factor: 3.466

View more
  1 in total

1.  Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.

Authors:  Shinichiro Kawamoto; Katsuya Yamamoto; Masanori Toyoda; Kimikazu Yakushijin; Hiroshi Matsuoka; Hironobu Minami
Journal:  Int J Hematol       Date:  2016-09-29       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.